Sandoz opens high-volume biosimilar manufacturing centre in Lendava

The facility in Slovenia is designed to strengthen Sandoz's in-house biosimilar production capacity and flexibility across its European network. The company says the centre employs over 300 experts and complements sites in Toulouse and Ljubljana.